Aristippos Gennadios - Catalent President - Softgel Technologies
| 0C8 Stock | EUR 59.93 0.29 0.48% |
President
Dr. Aristippos Gennadios is President Softgel Technologies of the Company. Previously, Dr. Gennadios has served as our President, Softgel Technologies since September 2013. Previously, he served as Vice President and General Manager of Softgel Technologies. Dr. Gennadios has worked in the pharmaceutical industry since 1996 in roles including RD, field sales, business development, operations and leadership. He joined our predecessor company, Cardinal Health, in 2002 and has held several key leadership posts within the softgel technologies business, including Global Vice President of Business Development for Softgel Technologies, General Manager of the Oral Development Center in Somerset, NJ, and Vice President and General Manager for Prescription Softgel and Consumer Health products since 2013.
| Age | 57 |
| Tenure | 11 years |
| Professional Marks | MBA |
| Phone | 732 537 6200 |
| Web | https://www.catalent.com |
Aristippos Gennadios Latest Insider Activity
Tracking and analyzing the buying and selling activities of Aristippos Gennadios against Catalent stock is an integral part of due diligence when investing in Catalent. Aristippos Gennadios insider activity provides valuable insight into whether Catalent is net buyers or sellers over its current business cycle. Note, Catalent insiders must abide by specific rules, including filing SEC forms every time they buy or sell Catalent'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Aristippos Gennadios over three months ago Disposition of 349 shares by Aristippos Gennadios of Catalent at 58.7 subject to Rule 16b-3 | ||
Aristippos Gennadios over three months ago Acquisition by Aristippos Gennadios of 18746 shares of Catalent subject to Rule 16b-3 |
Catalent Management Efficiency
The company has return on total asset (ROA) of 0.041 % which means that it generated a profit of $0.041 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0873 %, meaning that it generated $0.0873 on every $100 dollars invested by stockholders. Catalent's management efficiency ratios could be used to measure how well Catalent manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 4 records | PRESIDENT Age | ||
| Heidi Chen | Zoetis Inc | 56 | |
| Roxanne Lagano | Zoetis Inc | 58 | |
| Kristin Peck | Zoetis Inc | 52 | |
| Glenn David | Zoetis Inc | 51 | |
Management Performance
| Return On Equity | 0.0873 | |||
| Return On Asset | 0.041 |
Catalent Leadership Team
Elected by the shareholders, the Catalent's board of directors comprises two types of representatives: Catalent inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Catalent. The board's role is to monitor Catalent's management team and ensure that shareholders' interests are well served. Catalent's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Catalent's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Castellano, VP CFO | ||
| Paul Surdez, VP Relations | ||
| Steven Esq, Corp VP | ||
| Julien Meissonnier, VP Officer | ||
| Karen Santiago, VP Office | ||
| Ricky Hopson, Pres Supply | ||
| Charles Lickfold, VP Officer | ||
| Aristippos Gennadios, President - Softgel Technologies | ||
| John Chiminski, Chairman of the Board and Presidentident, CEO | ||
| Alessandro Maselli, Senior Vice President - Global Operations |
Catalent Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Catalent a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0873 | |||
| Return On Asset | 0.041 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 11.57 B | |||
| Shares Outstanding | 180.09 M | |||
| Shares Owned By Insiders | 0.36 % | |||
| Shares Owned By Institutions | 99.64 % | |||
| Price To Earning | 44.99 X | |||
| Price To Book | 1.76 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Catalent Stock
When determining whether Catalent is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Catalent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Catalent Stock. Highlighted below are key reports to facilitate an investment decision about Catalent Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Catalent. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Catalent Stock please use our How to Invest in Catalent guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.